MDM2 interacts with and downregulates a sarcomeric protein, TCAP

Biochemical and Biophysical Research Communications

Volumn 345, Issue 1, 2006, Pages 355-361

  Tian, Li Feng ^a   Li, Hui Yan ^a   Jin, Bao Feng ^a   Pan, Xin ^a   Man, Jiang Hong ^a   Zhang, Pei Jing ^a   Li, Wei Hua ^a   Liang, Bing ^a   Liu, Hui ^a   Zhao, Jie ^a   Gong, Wei Li ^a   Zhou, Tao ^a   Zhang, Xue Min ^a  

^a NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

Author keywords

Cardiac hypertrophy; Degradation; Interaction; MDM2; p14ARF; TCAP; Yeast two hybrid screen

Indexed keywords

GLUTATHIONE TRANSFERASE; PROTEIN; PROTEIN MDM2; PROTEIN P14ARF; TITIN CAP; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TWO HYBRID SYSTEM; YEAST;

DOWN-REGULATION; MUSCLE PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS C-MDM2; SARCOMERES; SUBCELLULAR FRACTIONS;

EID: 33646391986     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.108     Document Type: Article

References (33)

1. Momand J., Zambetti G.P., Olson D.C., George D., and Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69 (1992) 1237-1245
2. Roth J., Dobbelstein M., Freedman D.A., Shenk T., and Levine A.J. Nucleocytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17 (1998) 554-564
3. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
4. Kubbutat M.H., Jones S.N., and Vousden K.H. Regulation of p53 stability by Mdm2. Nature 387 (1997) 299-303
5. Haupt Y., Barak Y., and Oren M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15 (1996) 1596-1606
6. Chen J., Wu X., Lin J., and Levine A.J. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16 (1996) 2445-2452
7. Chen C.Y., Oliner J.D., Zhan Q., Fornace A.J., Vogelstein B., and Kastan M.B. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. USA 91 (1994) 2684-2688
8. Xiao Z.J., Chen J., Levine A.J., Modjtahedi N., Xing J., Sellers W.R., and Livingston D.M. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375 (1995) 694-698
9. Martin K., Trouche D., Hagemeier C., Sorensen T.S., La Thangue N.B., and Kouzarides T. Stimulation of E2F/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375 (1995) 691-694
10. Boyd T.M., Vlatkovic N., and Haines D.S. A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2. J. Biol. Chem. 275 (2000) 31883-31890
11. Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y., and Oren M. The Mdm2 oncoprotein interacts with the cell fate regulator Numb. Mol. Cell. Biol. 18 (1998) 3947-3982
12. Jin Y., Lee H., Zeng S.X., Dai M.S., and Lu H. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J. 23 (2003) 6365-6377
13. Weber J.D., Taylor L.J., Roussel M.F., Sherr C.J., and Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1 (1999) 20-26
14. De Graaf P., Little N.A., Ramos Y.F., Meulmeester E., Letteboer S.J., and Jochemsen A.G. Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2. J. Biol. Chem. 278 (2003) 38315-38324
15. Pan Y., and Chen J. MDM2 promotes ubiquitination and degradation of MDMX. Mol. Cell. Biol. 23 (2003) 5113-5121
16. Toth A., Nickson P., Qin L.L., and Erhardt P. Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J. Biol. Chem. 281 (2006) 3679-3689
17. Valle G., Faulkner G., De Antoni A., Pacchioni B., Pallavicini A., Pandolfo D., Tiso N., Toppo S., Trevisan S., and Lanfranchi G. Telethonin, a novel sarcomeric protein of heart and skeletal muscle. FEBS Lett. 415 (1997) 163-168
18. Mayans O., van der Ven P.F., Wilm M., Mues A., Young P., Furst D.O., Wilmanns M., and Gautel M. Structural basis for activation of the titin kinase domain during myofibrillogenesis. Nature 395 (1998) 863-869
19. Hayashi T., Arimura T., Itoh-Satoh M., Ueda K., Hohda S., Inagaki N., Takahashi M., Hori H., Yasunami M., Nishi H., Koga Y., Nakamura H., Matsuzaki M., Choi B.Y., Bae S.W., You C.W., Han K.H., Park J.E., Knoll R., Hoshijima M., Chien K.R., and Kimura A. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 2192-2201
20. Moreira E.S., Wiltshire T.J., Faulkner G., Nilforoushan A., Vainzof M., Suzuki O.T., Valle G., Reeves R., Zatz M., Passos-Bueno M.R., and Jenne D.E. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat. Genet. 24 (2000) 163-166
21. Knoll R., Hoshijima M., Hoffman H.M., Person V., Lorenzen-Schmidt I., Bang M.L., Hayashi T., Shiga N., Yasukawa H., Schaper W., McKenna W., Yokoyama M., Schork N.J., Omens J.H., McCulloch A.D., Kimura A., Gregorio C.C., Poller W., Schaper J., Schultheiss H.P., and Chien K.R. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111 (2002) 943-955
22. Kojic S., Medeot E., Guccione E., Krmac H., Zara I., Martinelli V., Valle G., and Faulkner G. The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J. Mol. Biol. 339 (2004) 313-325
23. Nicholas G., Thomas M., Langley B., Somers W., Patel K., Kemp C.F., Sharma M., and Kambadur R. Titin-cap associates with, and regulates secretion of, Myostatin. J. Cell. Physiol. 193 (2002) 120-131
24. Furukawa T., Ono Y., Tsuchiya H., Katayama Y., Bang M.L., Labeit D., Labeit S., Inagaki N., and Gregorio C.C. Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system. J. Mol. Biol. 313 (2001) 775-784
25. Haworth R.S., Cuello F., Herron T.J., Franzen G., Kentish J.C., Gautel M., and Avkiran M. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ. Res. 95 (2004) 1091-1099
26. Vainzof M., Moreira E.S., Suzuki O.T., Faulkner G., Valle G., Beggs A.H.O., Carpen O., Ribeiro A.F., Zanoteli E., Gurgel-Gianneti J., Tsanaclis A.M., Silva H.C., Passos-Bueno M.R., and Zatz M. Telethonin protein expression in neuromuscular disorders. Biochim. Biophys. Acta 1588 (2002) 33-40
27. Kubbutat M.H., Ludwig R.L., Levine A.J., and Vousden K.H. Analysis of the degradation function of Mdm2. Cell Growth Differ. 10 (1999) 87-92
28. Honda R., and Yasuda H. Association of p19 (ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18 (1999) 22-27
29. Xirodimas D., Saville M.K., Edling C., Lane D.P., and Lain S. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20 (2001) 4972-4983
30. Behrens J., von Kris J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., and Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382 (1996) 638-642
31. Molenaar M., van de Wetering M., Oosterwegel M., Peterson M.J., Godsave S., Korinek V., Roose J., Destree O., and Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86 (1996) 391-399
32. waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J. 22 (2003) 6365-6377
33. Sdek P., Ying H., Chang D.L., Qiu W., Zheng H., Touitou R., Allday M.J., and Xiao Z.X. MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol. Cell 20 (2005) 699-708